Clinical Trials
2 trialsNCT02267707 2019-11-01
Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia
Celgene
Phase 1 Terminated
NCT00080236 2012-08-10
Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation
Conatus Pharmaceuticals Inc.
Phase 2 Completed